Methotrexate with leucovorin rescue in the treatment of gynecologic malignancies. Preliminary report

Experience with chemotherapy in advanced gynecologic malignancies is limited. In 6 patients, 2 of 4 with carcinoma of the cervix, and 1 patient with carcinoma of the ovary achieved partial remission when treated with a regimen of high dose methotrexate (240 mg/m2) followed by leucovorin rescue. On p...

Full description

Saved in:

Bibliographic Details
Published in:	Oncology Vol. 32; no. 5-6; p. 275
Main Authors:	Corder, M P, Hively, L F, Stone, W H, Flannery, E P, Justice, G R
Format:	Journal Article
Language:	English
Published:	Switzerland 1975
Subjects:	Adult Aged Carcinoma, Squamous Cell - drug therapy Drug Therapy, Combination Female Genital Neoplasms, Female - drug therapy Humans Leucovorin - adverse effects Leucovorin - therapeutic use Methotrexate - adverse effects Methotrexate - therapeutic use Middle Aged Ovarian Neoplasms - drug therapy Pregnancy Trophoblastic Neoplasms - drug therapy Uterine Cervical Neoplasms - drug therapy Uterine Neoplasms - drug therapy
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Experience with chemotherapy in advanced gynecologic malignancies is limited. In 6 patients, 2 of 4 with carcinoma of the cervix, and 1 patient with carcinoma of the ovary achieved partial remission when treated with a regimen of high dose methotrexate (240 mg/m2) followed by leucovorin rescue. On patient with metastatic trophoblastic disease achieved complete response (greater than 24 months). The number of doses of leucovorin 'rescue' was based on creatinine clearance. The advantage of rapid response and moderate toxicity indicate the need for further study of this regimen in the treatment of gynecologic malignancies.
ISSN:	0030-2414
DOI:	10.1159/000225077